Navigation Links
Two New Imaging Studies Show Higher Dose Lipitor Stopped the,Progression of Atherosclerosis

SPARCL Study

The SPARCL study, published in the New England Journal of Medicine in 2006, is the only study to date evaluating the benefits of a statin solely in patients with a prior stroke or mini-stroke (n=4,731). Lipitor 80 mg reduced the risk of an additional stroke by 16 percent and major coronary events by 35 percent compared with placebo. In a post-hoc analysis of the SPARCL trial, there was a higher incidence of hemorrhagic stroke in patients taking Lipitor 80 mg compared with patients taking placebo. Patients with prior hemorrhagic stroke at study entry appeared to be at an increased risk of hemorrhagic stroke.

In SPARCL, Lipitor was well-tolerated. The rate of side effects such as elevated liver enzymes, muscle weakness or rhabdomyolysis were low and consistent with the known safety profile.

Important U.S. Prescribing Information

Lipitor is a prescription medication. It is used in patients with multiple risk factors for heart disease such as family history, high blood pressure, age, low HDL ("good" cholesterol) or smoking to reduce the risk of a heart attack, stroke, certain types of heart surgery and chest pain.

Lipitor is also used in patients with type 2 diabetes and at least one other risk factor for heart disease such as high blood pressure, smoking or complications of diabetes, including eye disease and protein in urine, to reduce the risk of heart attack and stroke.

Lipitor is used in patients with existing coronary heart disease to reduce the risk of heart attack, stroke, certain kinds of heart surgery, hospitalization for heart failure, and chest pain. Lipitor is not indicated for atherosclerosis.

When diet and exercise alone are not enough, Lipitor is used along with a low-fat diet and exercise to lower cholesterol.

Lipitor is not for everyone. It is not for those with liver problems. And it is not for women who are nursing, pregnant or may become pregnant.

Patients taking Lipitor sho
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data on Molecular Imaging Pharmaceutical for Prostate Cancer
2. Repligen Reports Positive Phase 2 Clinical Trial Results of Secretin for MRI Imaging of the Pancreas
3. Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimers Disease Presented at AD/PD Meeting
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
6. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
7. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
8. Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants
9. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
10. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
11. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
Post Your Comments:
(Date:11/21/2014)... --  Wellcentive , the industry leader in end-to-end ... today being named one of the four finalists ...  Sponsored by Intel, the world leader in computing ... companies developing leading-edge technology and unique approaches to ... Wellcentive,s Mason Beard , senior vice ...
(Date:11/21/2014)... , Nov. 21, 2014  Lexicon Pharmaceuticals, Inc. (Nasdaq: ... priced its offering of $80,000,000 aggregate principal amount of ... in a private offering within the United ... qualified institutional buyers pursuant to Rule 144A under the ... Lexicon has also granted the initial purchasers an option ...
(Date:11/18/2014)... 2014 Respiratory Motion and IMI Co announced ... and services providers in Japan , ... innovative respiratory depression monitor, the ExSpiron™. As part of ... together to connect the clinical community in promoting patient ... bringing innovative medical devices and new technology to the ...
Breaking Medicine Technology:Wellcentive Named Finalist for 2014 Intel Innovation Award 2Wellcentive Named Finalist for 2014 Intel Innovation Award 3Lexicon Announces Pricing Of Convertible Senior Notes Offering 2Lexicon Announces Pricing Of Convertible Senior Notes Offering 3Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 2Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 3Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 4
... Sept. 23, 2011 A pharmaceutical company,s marketing strategy ... introducing a new brand in a space where the ... two-thirds of companies, the most frequent changes require shifting ... activities, such as professional relations, promotional literature, sampling, and ...
... 2011 Watson Pharmaceuticals, Inc. (NYSE: WPI ), ... Company intends to release its third quarter 2011 financial results ... the U.S. financial markets.  The Company will also host a ... November 1, 2011 to discuss its financial results and provide ...
Cached Medicine Technology:Pharmaceutical Marketing Strategy Balances Support Between New & Established Products in the Same Indication 2Watson to Host Conference Call and Webcast to Discuss Third Quarter 2011 Earnings 2
(Date:11/21/2014)... -- Scientists say they,ve mapped the genome -- the genetic ... brain, in hopes it might help others with this very ... Genome Biology , the tapeworm was removed from the ... "This infection is so rare worldwide and completely unexpected in ... the worm was pulled out from the brain," study lead ...
(Date:11/21/2014)... The Ohio Children’s Trust Fund has agreed ... Academy of Pediatrics (Ohio AAP, [http://www.ohioaap.org ) to ... and caregivers throughout Ohio. The new contract, which began ... $75,000 to continue the campaign that originally started in ... excited to continue partnering with the Ohio AAP to ...
(Date:11/21/2014)... DC (PRWEB) November 21, 2014 Midway ... Atlantic Information Services, Inc.’s (AIS) annual Directory of Health ... plan market. AIS’s Directory of Health Plans is a ... health plans operating in the U.S. The 2015 ... far, researchers in AIS’s Directory and Databases Division, the ...
(Date:11/21/2014)... Los Angeles, CA (PRWEB) November 21, 2014 ... coding reference for the dental practice. It includes everything ... pages . , Procedure Coding with CDT , CDT ... services provided from January 1, 2014 - December 31, ... to report procedures and services on dental claims. There ...
(Date:11/21/2014)... India (PRWEB) November 21, 2014 RankingBySEO ... and manage the online reputation of lawyers, and the ... RankingBySEO has announced the service for lawyers since it ... their online reputation in big numbers. So far, the ... lawyers and law firms in different parts of the ...
Breaking Medicine News(10 mins):Health News:Ick! Tapeworm Infecting Man's Brain Yields Genetic Secrets 2Health News:Ohio AAP and Ohio Children’s Trust Fund Continue Partnership for Safe Sleep Education Campaign 2Health News:Ohio AAP and Ohio Children’s Trust Fund Continue Partnership for Safe Sleep Education Campaign 3Health News:Data from Atlantic Information Services’s Forthcoming Directory Shows Volatility in U.S. Health Care Market 2Health News:PMIC Announces CDT PLUS! 2015, the Ultimate Coding Reference for Dentists and Oral Surgeons 2Health News:RankingBySEO Announces Lawyer Reputation Management Service 2
... Thomas Jefferson University have found that a lower ... results in better hearing preservation and has the ... dose of therapy. The study appeared online in ... , "We previously had not determined the optimal ...
... 17 Protocol Driven Healthcare, Inc. (PDHI) announced today that two of its ... Quality Assurance (NCQA), an independent nonprofit organization that assesses and reports on the ... , ConXus Profile health risk ... Steps consumer health tools (wellness programs) - HIP 2 , ...
... for itchy skin condition , , WEDNESDAY, Dec. 17 (HealthDay News) ... to the development of eczema may one day lead to ... -- at least if new research with mice applies to ... of mice -- one that had a receptor for the ...
... , , WATERTOWN, Mass., Dec. ... Practice at Bright Horizons indicates that members of the sandwich ... are increasingly concerned about the balance of work and responding ... the same study confirms that employers who provide back-up child ...
... the journal Circulation on 8 December 2008 concluded ... rate following acute myocardial infarction, women with STEMI had an ... versus 5.5%). These differences were associated with a lower likelihood ... in the press, with suggestions of disparity in care and ...
... has found that being circumcised significantly reduced the risk ... to have been exposed to the virus. The findings ... where interventional use of adult male circumcision similarly reduced ... findings of the new study, along with similar results ...
Cached Medicine News:Health News:Lower-dose fractionated stereotactic radiotherapy results in better hearing preservation 2Health News:PDHI's Health Risk Appraisal and Consumer Health Tools Awarded NCQA HIP Certification 2Health News:Manipulating Key Protein May Prevent Eczema 2Health News:Study: Sandwich Generation Struggling With Dual Caregiver Responsibilities 2Health News:Study: Sandwich Generation Struggling With Dual Caregiver Responsibilities 3Health News:An ESC statement on gender differences in medical care and survival after myocardial infarction 2Health News:Circumcision reduces the risk of HIV infection in heterosexual US men 2
Penfield Watchmaker Forceps. Tip width 0.9 mm....
Vertigraft femoral shaft an large femoral cross-section designed primarily for use in lumbar corpectomy procedures. Freeze dried preservation....
... Ocelot stackable cage system provides anterior column ... total vertebrectomies from T1 to L5. The ... Carbon fiber polymer cages that are stacked ... needs. The Peek Carbon fiber reinforced polymer ...
... bone graft substitute (beta-tricalcium ... Chronos is an advantageous ... It shortens operative time, ... quantity and quality of ...
Medicine Products: